Due to technical issues, the Customer Support line is currently unavailable. Please use the live chat or email communication.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Andalas Energy LSE:ADL London Ordinary Share IM00BZ7PNY71 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.21p 0.20p 0.22p 0.21p 0.21p 0.21p 77,610 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Alternative Energy 0.0 -1.0 -0.0 - 1.27

Andalas Energy And Power Share Discussion Threads

Showing 4576 to 4592 of 5050 messages
Chat Pages: Latest  190  189  188  187  186  185  184  183  182  181  180  179  Older
DateSubjectAuthorDiscuss
30/6/2018
17:20
"However they have exposure to a massive Indonesian market" Out side of ADL RNS's from the DW days and recent ramping from the former bank robber there is no evidence what so ever that they genuinely do have anything at all to offer in Indonesia. Can you name another AIM company that has achieve 3 consecutive going concern emphasis of matters in just over 2 years since readmission? I can name plenty of former AIM companies with better prospects than ADL that are now liquidated with shareholders losing everything. Keep buying morons! ignore the hard facts and believe in fairy tales told by former bank robbers.
sweet karolina
30/6/2018
07:24
If you think you are so knowledgeable suggest just one star performer for 2018 to multi bag? Put your big gob on the line rather than just droning on and on... & on.Otherwise go away cause your all hot air.Mine is MNC metminco, they are due drilling results soon on a big columbian resource and already have a 70m NPV proven resource via a feasibility study that can leverage the same plant as propects once built. I have a small punt in ADL and I realise the risk. However they have exposure to a massive Indonesian market that has proveable short to medium term need for power as the county develops. ADL has some partners and MOU's that may or may not capatalise on that opportunity. Yes funding is unclear but the government of indo is involved which may back a project with a ingrained loan. Yes we may have another dilution but AIM companies take a decade to get her going, ADL is getting there I feel. I have risked here what I can afford to loose.GLA & DYOR (especially sweets ?)
chesycustard
29/6/2018
20:24
So you can't manage to put you assessment/research skills on the line then?Thought so :)
chesycustard
29/6/2018
16:26
So much effort into a share you don't hold. You must research a lot the ones you do. Give us a recommendation for the rest of 2018, be nice to hear you say something that's not negative!
chesycustard
29/6/2018
16:21
I wonder what the hold up is with AUDITED results? Is Gorringe now regretting promising results in Jun now he has seen the 3rd consecutive going concern emphasis of matter since readmission just over 2 years ago the auditors will publish with the accounts?
sweet karolina
29/6/2018
13:59
intra day reversal...big background buyer back...mm's have been collecting stock for several days now...look forward to Indonesia news... hxxps://theinsiderstories.com/uks-andalas-energy-looking-indonesian-asset/
pre
29/6/2018
12:36
Hope so but there's not a lot of volume today
johncb
29/6/2018
10:32
Sooner than I thought!
domple
29/6/2018
09:08
Yes. Back up to the 30s soon enough.
domple
28/6/2018
18:12
* The Company expects to announce and publish its audited accounts for the year ended 30 April 2018 (the "Accounts") in June 2018; Will we see them tomorrow or will this be the first of many broken promises from the new Messiah Gorringe?
sweet karolina
28/6/2018
12:51
ADL -mm's taking plenty...i think a big buy order is being filled here folks.
pre
28/6/2018
12:46
Chaps Farn just moved 10%. delayed reaction. Faron Pharmaceuticals Oy Clevegen successful toxicity studies 28/06/2018 7:01am RNS Non-Regulatory TIDMFARN Faron Pharmaceuticals Oy 28 June 2018 Faron Pharmaceuticals Ltd ("Faron" or the "Company") Clevegen shows good safety and potential to block Clever-1 on circulating monocytes -- Wholly-owned Clevegen (FP-1305) shows no toxicity in dose escalation studies in large preclinical models -- The no-observed-adverse-effect-level (NOAEL) was 100 mg/kg, which is roughly 30 times higher concentration than needed for Clever-1 occupancy in vivo -- Clevegen also blocked Clever-1 on circulating monocytes as expected. The duration of blocking was dose dependent and resumed to normal level in 20 days in the highest dose -- The Company expects CTA filing for MATINS study in Q3 2018 and first patient recruitment in Q4 2018 TURKU - FINLAND, 28 June 2018 - Faron Pharmaceuticals Ltd ("Faron") (AIM: FARN), the clinical stage biopharmaceutical company, today announces successful toxicity studies and control of blood Clever-1 positive monocytes, precursor cells to tumour associated macrophages (TAM) in large preclinical models. The toxicity studies were designed to fulfil regulatory requirements for 3-week interval intravenous administration of Clevegen, typical for other anti-cancer antibodies currently in use. FP-1305 is a humanized IgG4 monoclonal antibody produced in CHO -cells by Faron collaborator Abzena. The FP-1305 drug product in its final formulation was administered as a single dose at 3, 30 and 100 mg/kg. No toxicologically relevant changes were observed in any subject. No major changes were observed after treatment with FP-1305 in T lymphocytes subsets. The binding of Clevegen to its receptor on circulating CD14+ monocytes was confirmed by investigating the receptor occupancy, the recovery of which occurred between 3 to 20 days after dosing in a dose-dependent manner. No relevant changes were present in cytokines and no anti-drug antibodies (ADA) were detected in any subject. Therefore, the highest dose of 100 mg/kg was considered the no-observed-adverse-effect-level (NOAEL).
1lilac
28/6/2018
12:38
0.0234 to buy at present so many buys showing as sells
maytrees
28/6/2018
08:34
It'll be a complete lockout, you won't be able to buy unless you are in before the news lands.
jace86
27/6/2018
16:57
Going to be some hefty gains in next week. Mark my words
ernestsyngen
27/6/2018
00:04
Can't believe theyve dragged in mugs to keep buying this con.
tidy 2
26/6/2018
18:12
Ron.. Im going for 5-0 England :-)
therealtonythetiger
Chat Pages: Latest  190  189  188  187  186  185  184  183  182  181  180  179  Older
Your Recent History
LSE
ADL
Andalas En..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190425 10:25:31